CVS Health stock traded at USD 72.6 per share at the end 2019 translating into a market capitalization of USD 96,726 mil. Since the end of 2014, the stock has depreciated by 13.1% representing an annual average growth of -2.78%.
At the end of 2019, the firm traded at price to earnings of 14.3x. Over the last five years, this multiple achieved a high of 18.6x in 2015 and a low of -109x in 2018 with an average of -10.2x.
Regarding cash generated defined by the sum of net profit and depreciation, the stock traded at 11.1x at the end of 2019. When investments are excluded to get free cash flow, CVS Health traded at 9.97x.
At the end of 2019, the company had a net debt of USD 80,946 mil, or 4.25x of EBITDA and 126% of equity. The firm generated an average return on equity of 11.1% for its shareholders in the last five years and an average dividend yield of 2.60%.